In the near future, the story of drugs like Ozempic may no longer be primarily about weight loss and diabetes. These drugs, as we've learned, could also significantly reduce heart and kidney disease risks, slow dementia progression, aid fertility, and even lower COVID mortality rates. This complexity pushes us to rethink the nature of their impact, linking back not just to weight loss, but to inflammation as a key driver of many diseases.
Inflammation has been seen largely as a necessary defense mechanism, essential for survival against pathogens. However, ongoing research is reshaping this view, revealing that chronic inflammation, which remains present even in the absence of immediate threats, can actively contribute to various illnesses, including heart disease, dementia, and other chronic conditions. This shift in understanding suggests that managing inflammation could hold the key to outcomes in numerous health contexts.
Collection
[
|
...
]